April 21, 2020
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus
Download publicationBrochures
November 8, 2021
Immune Monitoring
More infoInfographics
November 5, 2021
Histopathology
More info